glp-1 and antibiotics Oral Medication Helps Patients Maintain Weight Loss | Newsroom GLP-1 Weight Loss Options |

Oral semaglutide 25 mg (Wegovy pill) , FDA-approved December 22, 2025, is the first oral GLP-1 approved for chronic weight management

serious risks include pancreatitis and gallbladder disease

Gradual dose titration significantly reduces gastrointestinal intolerance

Available: [37] B

Young: So, you know, caveating those are mostly white, male, older, you know, individuals, but it was really striking because these are also people with type 2 diabetes, and they were evaluating a variety of different GLP-1 uses

While GLP-1 therapies to date have conventionally been injectables, oral formulations are beginning to make their mark on the back of convenience and, therefore, better patient compliance